Fenpropimorph

Fenpropimorph

SCHEMBL465559

CC(Cc1ccc(C(C)(C)C)cc1)CN1CCCCC1.CC(Cc1ccc(C(C)(C)C)cc1)CN1C[C@@H](C)O[C@@H](C)C1

nearest known ligand 0.86

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 7/20 0.86
EBP Q15125 1/20 0.86
ADORA3 P0DMS8 1/20 0.69
CHRM1 P11229 1/20 0.69
DRD3 P35462 1/20 0.69
KCNH2 Q12809 1/20 0.69
HRH3 Q9Y5N1 3/20 0.40
KDM4E B2RXH2 1/20 0.39
GRIN2D O15399 1/20 0.37
GRIN3B O60391 1/20 0.37
ADRA1D P25100 1/20 0.37
ADRA1A P35348 1/20 0.37
ADRA1B P35368 1/20 0.37
GRIN1 Q05586 1/20 0.37
GRIN2A Q12879 1/20 0.37
GRIN2B Q13224 1/20 0.37
GRIN2C Q14957 1/20 0.37
GRIN3A Q8TCU5 1/20 0.37
L3MBTL1 Q9Y468 2/20 0.37
ALDH1A1 P00352 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Amorolfine SCHEMBL23111397 0.94 ADORA3 (0.81) SIGMAR1EBPADORA3CHRM1DRD3
Fenpropimorph SCHEMBL9164245 0.93 SIGMAR1 (1.00) SIGMAR1EBPADORA3CHRM1DRD3
Fenpropimorph SCHEMBL29455102 0.93 SIGMAR1 (1.00) SIGMAR1EBPADORA3CHRM1DRD3
Fenpropimorph SCHEMBL12473532 0.93 SIGMAR1 (1.00) SIGMAR1EBPADORA3CHRM1DRD3
Fenpropimorph SCHEMBL9020991 0.93 SIGMAR1 (1.00) SIGMAR1EBPADORA3CHRM1DRD3
Fenpropimorph SCHEMBL30367069 0.93 SIGMAR1 (1.00) SIGMAR1EBPADORA3CHRM1DRD3
Fenpropimorph SCHEMBL22363 0.93 SIGMAR1 (1.00) SIGMAR1EBPADORA3CHRM1DRD3
Fenpropimorph SCHEMBL7953741 0.93 SIGMAR1 (1.00) SIGMAR1EBPADORA3CHRM1DRD3
Fenpropimorph SCHEMBL22362 0.93 SIGMAR1 (1.00) SIGMAR1EBPADORA3CHRM1DRD3
Fenpropimorph SCHEMBL3710231 0.91 SIGMAR1 (0.97) SIGMAR1EBPADORA3CHRM1DRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 82 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170245492-A1 AGROCHEMICAL DELIVERY SYSTEM BASED ON ENZYME- OR pH- RESPONSIVE AMPHIPHILIC PEG-DENDRON HYBRIDS RAMOT AT TEL AVIV UNlVERSITY LTD. (IL) 2017-08-31 US claimed
EP-2061311-B1 PESTICIDE NANOPARTICLES OBTAINED FROM MICROEMULSIONS AND NANOEMULSIONS YISSUM RES DEV COMPANY OF THE HEBREW UNIV OF JERUSALEM (IL) 2017-08-02 EP claimed
EP-3190880-A1 AGROCHEMICAL DELIVERY SYSTEM BASED ON ENZYME- OR pH- RESPONSIVE AMPHIPHILIC PEG-DENDRON HYBRIDS Ramot at Tel-Aviv University Ltd. (IL) 2017-07-19 EP claimed
WO-2016038596-A1 AGROCHEMICAL DELIVERY SYSTEM BASED ON ENZYME- OR pH- RESPONSIVE AMPHIPHILIC PEG-DENDRON HYBRIDS RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) 2016-03-17 WO claimed
US-9095133-B2 Pesticide nanoparticles obtained from microemulsions and nanoemulsions YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) 2015-08-04 US claimed
EP-2632266-A1 PENFLUFEN AS A WOOD PRESERVATIVE AGAINST XYLOPHAGOUS BASIDIOMYCETES Lanxess Deutschland GmbH (DE) 2013-09-04 EP claimed
WO-2012055673-A1 PENFLUFEN AS A WOOD PRESERVATIVE AGAINST XYLOPHAGOUS BASIDIOMYCETES LANXESS DEUTSCHLAND GMBH (DE) 2012-05-03 WO claimed
EP-2443927-A1 Penflufen as agent for protecting woods against wood-destroying basidiomycetes LANXESS Deutschland GmbH (DE) 2012-04-25 EP claimed
US-20100015236-A1 PESTICIDE NANOPARTICLES OBTAINED FROM MICROEMULSIONS AND NANOEMULSIONS YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) 2010-01-21 US claimed
EP-2061311-A2 PESTICIDE NANOPARTICLES OBTAINED FROM MICROEMULSIONS AND NANOEMULSIONS Yissum Research Development Company of the Hebrew University of Jerusalem (IL) 2009-05-27 EP claimed
WO-2008032328-A2 PESTICIDE NANOPARTICLES OBTAINED FROM MICROEMULSIONS AND NANOEMULSIONS YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) 2008-03-20 WO claimed
CN-114163382-B Cyclobutanamide compound or salts and composition acceptable by pesticides and application thereof 海利尔药业集团股份有限公司 2024-02-27 CN disclosed
US-20230337680-A1 PENFLUFEN AS A WOOD PRESERVATIVE AGAINST WOOD-DESTROYING BASIDIOMYCETES LANXESS DEUTSCHLAND GMBH (DE) 2023-10-26 US disclosed
CN-116640136-A Sulfonamide compound or salt acceptable as pesticide, composition and application thereof 海利尔药业集团股份有限公司 2023-08-25 CN disclosed
US-11723368-B2 Penflufen as a wood preservative against wood-destroying basidiomycetes LANHESS Deutshcland GmbH 2023-08-15 US disclosed
WO-1998046607-A1 FUNGICIDAL TRIFLUOROPHENYL-TRIAZOLOPYRIMIDINES AMERICAN CYANAMID COMPANY (US) 1998-10-22 WO disclosed
WO-1998045258-A1 1-CYANO-2-ALKYLTHIO-2-ARYLTHIOETHENES BAYER AKTIENGESELLSCHAFT (DE) 1998-10-15 WO disclosed
WO-1998042689-A1 3-ALKOXY ISOTHIAZOLES BAYER AKTIENGESELLSCHAFT (DE) 1998-10-01 WO disclosed
WO-1998029400-A1 ARYLTHIO-DITHIAZINDIOXIDES AND THEIR USE AS PESTICIDES BAYER AKTIENGESELLSCHAFT (DE) 1998-07-09 WO disclosed
WO-1997047606-A1 ARYLOXYACRYLIC ACID ESTERS BAYER AKTIENGESELLSCHAFT (DE) 1997-12-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11723368-B2 Penflufen as a wood preservative against wood-destroying basidiomycetes BLVRB, DCXR, PAH SIGMAR1 4409/4885EBP 4196/4885ADORA3 626/4885
US-20230337680-A1 PENFLUFEN AS A WOOD PRESERVATIVE AGAINST WOOD-DESTROYING BASIDIOMYCETES BLVRB, DCXR, PAH SIGMAR1 4409/4885EBP 4196/4885ADORA3 626/4885
US-20170245492-A1 AGROCHEMICAL DELIVERY SYSTEM BASED ON ENZYME- OR pH- RESPONSIVE AMPHIPHILIC PEG-DENDRON HYBRIDS APEH, JMJD7, AGL SIGMAR1 2568/4885EBP 3124/4885ADORA3 3175/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.